Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18 03:00

Janux Therapeutics Price Target Maintained With a $200.00/Share by Cantor Fitzgerald

Dow JonesDec 12 00:37 · Ratings

Janux Therapeutics Analyst Ratings

BenzingaDec 12 00:25 · Ratings

BTIG Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $100

Futu NewsDec 10 18:36 · Ratings

BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TipRanksDec 10 18:27 · Ratings

SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?

BenzingaDec 8 23:15